Bill > HB382

This bill, titled the "Prescription Drug Security, Supervision, and Return Act," makes several changes to Georgia law, primarily concerning controlled substances and pharmacy operations. It revises the definition of Schedule I controlled substances to exclude specific FDA-approved drugs containing lysergide tartrate (a form of LSD) and crystalline polymorph psilocybin, provided they are also scheduled by the U.S. Drug Enforcement Administration and listed in the federal Controlled Substances Act. The bill also modifies the responsibilities of pharmacists and pharmacy technicians, allowing technicians to perform certain technical functions remotely and establishing a supervisory ratio of one pharmacist to four technicians within the licensed pharmacy area, with exceptions for hospital and closed-door pharmacies. Additionally, it removes a previous restriction on the State Board of Pharmacy requiring wholesale drug distributors to accept returns of essential healthcare drugs only if their expiration date was less than one year from manufacturing. The effectiveness of the changes related to lysergide tartrate and psilocybin is contingent on their federal approval and scheduling.